Literature DB >> 17061286

Neurodevelopment and chronic illness: Mechanisms of disease and treatment.

F Daniel Armstrong1.   

Abstract

Successful treatment of many childhood diseases once considered terminal has resulted in the emergence of long-term effects of the disease or consequences of treatment that were previously unrecognized. Many of these long-term effects involve the central nervous system (CNS) and are developmental in the way that they emerge over time. Because we are now able to observe the natural history of childhood diseases such as sickle cell anemia or HIV, or the consequences of treatment of disease such as leukemia, brain tumors, or kidney disease, we are also able to study a number of biological mechanisms that result in long-term neurocognitive impairment. While some of the neurodevelopmental outcomes can be directly linked to structural damage of the CNS, other systems (e.g., hematologic, immunologic, pulmonary) appear to play crucial indirect roles in the development of the CNS and neurocognitive abilities because of the way that they affect the course of brain development and activity of the brain across time. Important interactions between acute disease factors, biological mechanisms, age at the time of disease or treatment effect, and disruptions in patterns of development after successful treatment or management all provide support for a neurodevelopmental model of childhood chronic illness. Testing this model may make it possible to more accurately predict the timing and degree of severity of long-term neurodevelopmental consequences, provide guidance for improved treatment and prevention, and offer better understanding of neurodevelopmental disruptions that occur in other non-chronic illness related disabilities. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 17061286     DOI: 10.1002/mrdd.20114

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  15 in total

1.  Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure.

Authors:  Patricia A Garvie; Bret Zeldow; Kathleen Malee; Sharon L Nichols; Renee A Smith; Megan L Wilkins; Paige L Williams
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Evidence of cerebral microbleeds and neurocognitive impairment following cranial radiation therapy for pediatric brain tumors: a new opportunity for improved care.

Authors:  F Daniel Armstrong
Journal:  Neuro Oncol       Date:  2016-11       Impact factor: 12.300

Review 3.  Neurocognitive outcomes in pediatric diabetes: a developmental perspective.

Authors:  David D Schwartz; Rachel Wasserman; Priscilla W Powell; Marni E Axelrad
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

4.  Intelligence and Academic Achievement of Adolescents with Craniofacial Microsomia.

Authors:  Matthew L Speltz; Erin R Wallace; Brent R Collett; Carrie L Heike; Daniela V Luquetti; Martha M Werler
Journal:  Plast Reconstr Surg       Date:  2017-09       Impact factor: 4.730

5.  Neurocognitive and functional outcomes at 5 years of age after renal transplant in early childhood.

Authors:  Jillian Popel; Rachel Joffe; Bryan V Acton; Gwen Y Bond; Ari R Joffe; Julian Midgley; Charlene M T Robertson; Reg S Sauve; Catherine J Morgan
Journal:  Pediatr Nephrol       Date:  2018-12-15       Impact factor: 3.714

6.  School outcomes in children registered in the studies for pediatric liver transplant (SPLIT) consortium.

Authors:  Susan M Gilmour; Lisa G Sorensen; Ravinder Anand; Wanrong Yin; Estella M Alonso
Journal:  Liver Transpl       Date:  2010-09       Impact factor: 5.799

7.  Developmental function in toddlers with sickle cell anemia.

Authors:  F Daniel Armstrong; T David Elkin; R Clark Brown; Penny Glass; Sohail Rana; James F Casella; Ram V Kalpatthi; Steven Pavlakis; Zhibao Mi; Winfred C Wang
Journal:  Pediatrics       Date:  2013-01-06       Impact factor: 7.124

8.  Predictors of Academic Achievement for School Age Children with Sickle Cell Disease.

Authors:  Kelsey E Smith; Chavis A Patterson; Margo M Szabo; Reem A Tarazi; Lamia P Barakat
Journal:  Adv Sch Ment Health Promot       Date:  2013-01-25

9.  Health-related quality of life of children with mild to moderate chronic kidney disease.

Authors:  Arlene C Gerson; Alicia Wentz; Allison G Abraham; Susan R Mendley; Stephen R Hooper; Robert W Butler; Debbie S Gipson; Marc B Lande; Shlomo Shinnar; Marva M Moxey-Mims; Bradley A Warady; Susan L Furth
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

10.  Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis.

Authors:  Adelaide Fernandes; Ana Sofia Falcão; Elsa Abranches; Evguenia Bekman; Domingos Henrique; Lorene M Lanier; Dora Brites
Journal:  Dev Neurobiol       Date:  2009-08       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.